Stuart Mair
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Inflammatory mediators and NSAID effects
Papers in
- Oncology 8
- Neutropenia and Cancer Infections 3
- Drug Transport and Resistance Mechanisms 2
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- Cornelius F. Waller (3 shared papers)Miguel H. Bronchud (3 shared papers)Lloyd Stevens (3 shared papers)Anshul Gupta (1 shared paper)Giorgia Rossi (1 shared paper)Timi Edeki (1 shared paper)Shampa Das (1 shared paper)Claudio Giuliano (1 shared paper)
- Journals
- Xenobiotica (4 papers)Drug Metabolism and Pharmacokinetics (2 papers)Blood (2 papers)Annals of Hematology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Stuart Mair
25 papers receiving 403 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 40
- Pharmacology 88
- Endocrinology, Diabetes and Metabolism 57
- Oncology 82
- Pharmacology 25
Countries citing papers authored by Stuart Mair
This map shows the geographic impact of Stuart Mair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Mair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Mair more than expected).
Fields of papers citing papers by Stuart Mair
This network shows the impact of papers produced by Stuart Mair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Mair. The network helps show where Stuart Mair may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Mair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 51 | |
| 2 | 2013 | 48 | |
| 3 | 2014 | 43 | |
| 4 | 2003 | 38 | |
| 5 | 2010 | 35 | |
| 6 | 2010 | 30 | |
| 7 | 2016 | 25 | |
| 8 | 2017 | 24 | |
| 9 | 2015 | 21 | |
| 10 | 2022 | 20 | |
| 11 | 2013 | 18 | |
| 12 | 2019 | 16 | |
| 13 | 2018 | 13 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 6 | |
| 17 | Initial Clinical Evaluation of Safety, Tolerability and Pharmacodynamics of the Locally-Acting ROCK Inhibitor AMA0076 | 2014 | 5 |
| 18 | 2020 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2009 | 1 |
About Stuart Mair
Stuart Mair is a scholar working on Oncology, Immunology, Pharmacology, Epidemiology and Physiology, having authored 27 papers that have together received 423 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (4 papers), Diabetes Treatment and Management (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Neutropenia and Cancer Infections (3 papers), Inflammatory mediators and NSAID effects (2 papers), Pneumonia and Respiratory Infections (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Anesthesia and Sedative Agents (2 papers). The work is most often cited by research in Molecular Medicine (40 citations), Pharmacology (88 citations), Endocrinology, Diabetes and Metabolism (57 citations), Oncology (82 citations) and Pharmacology (25 citations). Stuart Mair has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Cornelius F. Waller, Miguel H. Bronchud, Lloyd Stevens, Anshul Gupta, Giorgia Rossi, Timi Edeki, Shampa Das, Claudio Giuliano, Ian C. T. Nisbet and James Atherton. Their work appears in journals such as Xenobiotica, Drug Metabolism and Pharmacokinetics, Blood, Annals of Hematology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.